This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Bioventures, LLC, Cornell University, New York Botanical Garden. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Loja, EC (2021)
- Little Rock, AR (US) (2021)
Company Filing History:
2 out of 100 
2 out of 2,949 
1 out of 1 
Years Active: 2021
Title: Paola E Ordonez: Innovator in Cancer Research
Introduction
Paola E Ordonez is a prominent inventor based in Loja, Ecuador. She has made significant contributions to the field of cancer research through her innovative work and patented inventions. With a total of 2 patents, her research focuses on developing new methods to inhibit the growth of cancer cells.
Latest Patents
One of her latest patents is titled "Dehydroleucodine derivatives and uses thereof." This invention provides dehydroleucodine derivatives, particularly amine derivatives, and methods for using these compounds to inhibit the growth of cancer cells. Another notable patent is "Hetero-substituted cyclic lactone analogues and uses thereof." This disclosure presents SL and SL derivatives that include a polar substituent adjacent to the lactone ring, along with methods for using these derivatives to inhibit the growth of leukemic cancer cells.
Career Highlights
Paola has worked with esteemed institutions such as Cornell University and Bioventures, LLC. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Throughout her career, Paola has collaborated with notable individuals, including Cesar M Compadre and Monica L Guzman. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Paola E Ordonez is a dedicated inventor whose work in cancer research has led to valuable patents and collaborations. Her innovative contributions continue to pave the way for advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile